These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 2476663

  • 1. pp60c-src variants containing lesions that affect phosphorylation at tyrosines 416 and 527.
    Harvey R, Hehir KM, Smith AE, Cheng SH.
    Mol Cell Biol; 1989 Sep; 9(9):3647-56. PubMed ID: 2476663
    [Abstract] [Full Text] [Related]

  • 2. The carboxy terminus of pp60c-src is a regulatory domain and is involved in complex formation with the middle-T antigen of polyomavirus.
    Cheng SH, Piwnica-Worms H, Harvey RW, Roberts TM, Smith AE.
    Mol Cell Biol; 1988 Apr; 8(4):1736-47. PubMed ID: 2454396
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the effects of carboxyl terminal truncation and point mutations on pp60c-src activities.
    Yaciuk P, Cannella MT, Shalloway D.
    Oncogene Res; 1988 Sep; 3(2):207-12. PubMed ID: 2465526
    [Abstract] [Full Text] [Related]

  • 4. The amino-terminal region of pp60c-src has a modulatory role and contains multiple sites of tyrosine phosphorylation.
    Espino PC, Harvey R, Schweickhardt RL, White GA, Smith AE, Cheng SH.
    Oncogene; 1990 Mar; 5(3):283-93. PubMed ID: 1690377
    [Abstract] [Full Text] [Related]

  • 5. Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation.
    Kmiecik TE, Shalloway D.
    Cell; 1987 Apr 10; 49(1):65-73. PubMed ID: 3103925
    [Abstract] [Full Text] [Related]

  • 6. Selective binding of activated pp60c-src by an immobilized synthetic phosphopeptide modeled on the carboxyl terminus of pp60c-src.
    Roussel RR, Brodeur SR, Shalloway D, Laudano AP.
    Proc Natl Acad Sci U S A; 1991 Dec 01; 88(23):10696-700. PubMed ID: 1720546
    [Abstract] [Full Text] [Related]

  • 7. Mutation of amino acids in pp60c-src that are phosphorylated by protein kinases C and A.
    Yaciuk P, Choi JK, Shalloway D.
    Mol Cell Biol; 1989 Jun 01; 9(6):2453-63. PubMed ID: 2474754
    [Abstract] [Full Text] [Related]

  • 8. Regulation of the cellular src protein tyrosine kinase: interactions of the carboxyl terminal sequences residing between the kinase domain and tyrosine-527.
    Cobb BS, Parsons JT.
    Oncogene; 1993 Nov 01; 8(11):2897-903. PubMed ID: 7692368
    [Abstract] [Full Text] [Related]

  • 9. Dephosphorylation or antibody binding to the carboxy terminus stimulates pp60c-src.
    Cooper JA, King CS.
    Mol Cell Biol; 1986 Dec 01; 6(12):4467-77. PubMed ID: 2432403
    [Abstract] [Full Text] [Related]

  • 10. Activation of pp60c-src transforming potential by mutations altering the structure of an amino terminal domain containing residues 90-95.
    Potts WM, Reynolds AB, Lansing TJ, Parsons JT.
    Oncogene Res; 1988 Dec 01; 3(4):343-55. PubMed ID: 2465527
    [Abstract] [Full Text] [Related]

  • 11. Activation of pp60c-src tyrosine kinase specific activity in tumor-derived Syrian hamster embryo cells.
    Kanner SB, Parsons SJ, Parsons JT, Gilmer TM.
    Oncogene; 1988 Apr 01; 2(4):327-35. PubMed ID: 2452399
    [Abstract] [Full Text] [Related]

  • 12. Activation of the pp60c-src kinase by middle T antigen binding or by dephosphorylation.
    Courtneidge SA.
    EMBO J; 1985 Jun 01; 4(6):1471-7. PubMed ID: 2411538
    [Abstract] [Full Text] [Related]

  • 13. Structural and functional modification of pp60c-src associated with polyoma middle tumor antigen from infected or transformed cells.
    Cartwright CA, Hutchinson MA, Eckhart W.
    Mol Cell Biol; 1985 Oct 01; 5(10):2647-52. PubMed ID: 2426573
    [Abstract] [Full Text] [Related]

  • 14. Phosphorylation of tyrosine in the carboxyl-terminal tryptic peptide of pp60c-src.
    Laudano AP, Buchanan JM.
    Proc Natl Acad Sci U S A; 1986 Feb 01; 83(4):892-6. PubMed ID: 2419902
    [Abstract] [Full Text] [Related]

  • 15. Substitution of Ser-17 of pp60c-src: biological and biochemical characterization in chicken embryo fibroblasts.
    Hirota Y, Kato J, Takeya T.
    Mol Cell Biol; 1988 Apr 01; 8(4):1826-30. PubMed ID: 2454397
    [Abstract] [Full Text] [Related]

  • 16. The amino-terminal half of pp59c-fyn contains sequences necessary for formation of a 75 kDa form and also repressive elements absent in pp60c-src.
    Espino PC, Chou WY, Smith AE, Cheng SH.
    Oncogene; 1992 Feb 01; 7(2):317-22. PubMed ID: 1372400
    [Abstract] [Full Text] [Related]

  • 17. Structural elements that regulate pp59c-fyn catalytic activity, transforming potential, and ability to associate with polyomavirus middle-T antigen.
    Cheng SH, Espino PC, Marshall J, Harvey R, Merrill J, Smith AE.
    J Virol; 1991 Jan 01; 65(1):170-9. PubMed ID: 1985196
    [Abstract] [Full Text] [Related]

  • 18. Altered sites of tyrosine phosphorylation in pp60c-src associated with polyomavirus middle tumor antigen.
    Cartwright CA, Kaplan PL, Cooper JA, Hunter T, Eckhart W.
    Mol Cell Biol; 1986 May 01; 6(5):1562-70. PubMed ID: 2431281
    [Abstract] [Full Text] [Related]

  • 19. Regulation of the oncogenic activity of the cellular src protein requires the correct spacing between the kinase domain and the C-terminal phosphorylated tyrosine (Tyr-527).
    Cobb BS, Payne DM, Reynolds AB, Parsons JT.
    Mol Cell Biol; 1991 Dec 01; 11(12):5832-8. PubMed ID: 1719372
    [Abstract] [Full Text] [Related]

  • 20. c-Src and mitosis.
    Shalloway D, Bagrodia S, Chackalaparampil I, Shenoy S, Lin PH, Taylor SJ.
    Ciba Found Symp; 1992 Dec 01; 170():248-65; discussion 265-75. PubMed ID: 1282857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.